Company overview

Endo Pharmaceuticals Holdings (Endo) is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, overactive bladder, prostate cancer and central precocious puberty. The company primarily operates in the US. Endo is headquartered in Chadds Ford, Pennsylvania and employed 1,216 people as of December 31, 2008.

The company recorded revenues of $1,260.5 million during the financial year (FY) ended December 2008, an increase of 16.1% over FY2007. The operating profit of the company was $387.5 million during FY2008, an increase of 22.1% over FY2007. The net profit was $261.7 million in FY2008, an increase of 15.1% over FY2007.

Key facts

NASDAQ National Market ticker: ENDP

No. employees: 1216

Turnover: 1,260,536,000 (USD)

Financial year end: December

Summary

• Key facts
• Overview
• Business Description
• History
• Key Employees and Biographies
• Top Competitors
• Major Products and Services

SWOT Profiles

This SWOT analysis company profile is the essential source for top level data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Scope of this research

• Provides all the crucial company information required for business and competitor intelligence needs.
• Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
• Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Key reasons to purchase this research

• Support sales activities by understanding your customers' businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors' business structure, strategy and prospects
• Obtain the most up to date company information available